Alja Oblak

724 total citations
15 papers, 598 citations indexed

About

Alja Oblak is a scholar working on Immunology, Microbiology and Epidemiology. According to data from OpenAlex, Alja Oblak has authored 15 papers receiving a total of 598 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 6 papers in Microbiology and 5 papers in Epidemiology. Recurrent topics in Alja Oblak's work include Immune Response and Inflammation (14 papers), Antimicrobial Peptides and Activities (6 papers) and Pneumonia and Respiratory Infections (4 papers). Alja Oblak is often cited by papers focused on Immune Response and Inflammation (14 papers), Antimicrobial Peptides and Activities (6 papers) and Pneumonia and Respiratory Infections (4 papers). Alja Oblak collaborates with scholars based in Slovenia, United States and Spain. Alja Oblak's co-authors include Roman Jerala, Jerrold Weiss, Theresa L. Gioannini, Primož Pristovšek, Jelka Pohar, Paul Kosma, Alla Zamyatina, Sonsoles Martín‐Santamaría, Andreas Hofinger and Cécile Arrieumerlou and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Alja Oblak

15 papers receiving 592 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alja Oblak Slovenia 12 373 229 112 110 57 15 598
Aline Blaecke France 9 471 1.3× 237 1.0× 113 1.0× 65 0.6× 55 1.0× 9 822
Melinda Przetak United States 8 392 1.1× 224 1.0× 124 1.1× 57 0.5× 33 0.6× 12 626
Mahesh Chandra Patra India 16 307 0.8× 332 1.4× 63 0.6× 89 0.8× 64 1.1× 37 681
Brett Verstak United Kingdom 9 405 1.1× 174 0.8× 100 0.9× 50 0.5× 106 1.9× 10 570
Bettina Tippler Germany 15 186 0.5× 239 1.0× 193 1.7× 65 0.6× 98 1.7× 25 688
Clover Ching Man Wong Hong Kong 8 89 0.2× 296 1.3× 102 0.9× 126 1.1× 41 0.7× 10 476
Rainer Bartels Germany 10 246 0.7× 230 1.0× 44 0.4× 302 2.7× 37 0.6× 17 666
Valerie Sloane United States 6 192 0.5× 222 1.0× 50 0.4× 19 0.2× 33 0.6× 6 493
Seon-Ju Yeo South Korea 11 296 0.8× 132 0.6× 91 0.8× 34 0.3× 88 1.5× 14 520
Yusuke Takahashi Japan 13 237 0.6× 246 1.1× 118 1.1× 38 0.3× 68 1.2× 24 772

Countries citing papers authored by Alja Oblak

Since Specialization
Citations

This map shows the geographic impact of Alja Oblak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alja Oblak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alja Oblak more than expected).

Fields of papers citing papers by Alja Oblak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alja Oblak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alja Oblak. The network helps show where Alja Oblak may publish in the future.

Co-authorship network of co-authors of Alja Oblak

This figure shows the co-authorship network connecting the top 25 collaborators of Alja Oblak. A scholar is included among the top collaborators of Alja Oblak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alja Oblak. Alja Oblak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Oblak, Alja, Javier Klett, Sonsoles Martín‐Santamaría, et al.. (2016). Molecular Basis of the Functional Differences between Soluble Human Versus Murine MD-2: Role of Val135 in Transfer of Lipopolysaccharide from CD14 to MD-2. The Journal of Immunology. 196(5). 2309–2318. 9 indexed citations
2.
Ciaramelli, Carlotta, Valentina Calabrese, Javier Klett, et al.. (2016). Glycolipid‐based TLR4 Modulators and Fluorescent Probes: Rational Design, Synthesis, and Biological Properties. Chemical Biology & Drug Design. 88(2). 217–229. 12 indexed citations
3.
Lorenzo, Flaviana Di, Łukasz Kubik, Alja Oblak, et al.. (2015). Activation of Human Toll-like Receptor 4 (TLR4)·Myeloid Differentiation Factor 2 (MD-2) by Hypoacylated Lipopolysaccharide from a Clinical Isolate of Burkholderia cenocepacia. Journal of Biological Chemistry. 290(35). 21305–21319. 50 indexed citations
4.
Oblak, Alja, Jelka Pohar, & Roman Jerala. (2015). MD-2 Determinants of Nickel and Cobalt-Mediated Activation of Human TLR4. PLoS ONE. 10(3). e0120583–e0120583. 31 indexed citations
5.
Lebar, Tina, Martin Stražar, Mojca Benčina, et al.. (2014). A bistable genetic switch based on designable DNA-binding domains. Nature Communications. 5(1). 5007–5007. 63 indexed citations
6.
Oblak, Alja & Roman Jerala. (2014). Species-Specific Activation of TLR4 by Hypoacylated Endotoxins Governed by Residues 82 and 122 of MD-2. PLoS ONE. 9(9). e107520–e107520. 8 indexed citations
7.
Oblak, Alja & Roman Jerala. (2014). The molecular mechanism of species-specific recognition of lipopolysaccharides by the MD-2/TLR4 receptor complex. Molecular Immunology. 63(2). 134–142. 49 indexed citations
8.
Oblak, Alja, Duško Lainšček, José L. Jiménez Blanco, et al.. (2014). Trehalose- and Glucose-Derived Glycoamphiphiles: Small-Molecule and Nanoparticle Toll-Like Receptor 4 (TLR4) Modulators. Journal of Medicinal Chemistry. 57(21). 9105–9123. 27 indexed citations
9.
Stöckl, Johannes, Alja Oblak, Mira Haegman, et al.. (2014). Development of αGlcN(1↔1)αMan-Based Lipid A Mimetics as a Novel Class of Potent Toll-like Receptor 4 Agonists. Journal of Medicinal Chemistry. 57(19). 8056–8071. 23 indexed citations
10.
Oblak, Alja, et al.. (2014). Tetraacylated Lipid A and Paclitaxel-Selective Activation of TLR4/MD-2 Conferred through Hydrophobic Interactions. The Journal of Immunology. 192(4). 1887–1895. 17 indexed citations
11.
Oblak, Alja, José Antonio Gárate, Simon Horvat, et al.. (2013). Conformationally Constrained Lipid A Mimetics for Exploration of Structural Basis of TLR4/MD-2 Activation by Lipopolysaccharide. ACS Chemical Biology. 8(11). 2423–2432. 52 indexed citations
12.
Smole, Anže, et al.. (2012). Delivery system for the enhanced efficiency of immunostimulatory nucleic acids. Innate Immunity. 19(1). 53–65. 6 indexed citations
13.
Oblak, Alja & Roman Jerala. (2011). Toll-Like Receptor 4 Activation in Cancer Progression and Therapy. SHILAP Revista de lepidopterología. 2011. 1–12. 130 indexed citations
14.
Oblak, Alja, et al.. (2009). Novel Roles of Lysines 122, 125, and 58 in Functional Differences between Human and Murine MD-2. The Journal of Immunology. 183(8). 5138–5145. 21 indexed citations
15.
Oblak, Alja, et al.. (2009). Essential Roles of Hydrophobic Residues in Both MD-2 and Toll-like Receptor 4 in Activation by Endotoxin. Journal of Biological Chemistry. 284(22). 15052–15060. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026